Civilization Ventures is a venture capital firm focused on healthcare innovations. They back inspired founders solving essential problems in healthcare.

Civilization Ventures

At CV, we champion visionary founders tackling the most critical challenges in biology and healthcare. With a portfolio worth $9.7B, encompassing 64 companies and 9 successful exits, we provide the capital and resources necessary for innovators to thrive.

Pillo Health

Lemonaid Health

Rocket Pharmaceuticals

Singular Bio

We're humbled to announce the acquisition of Civilization Ventures portfolio company Fluent BioSciences Inc. by Illumina - our 10th exit in the fund!

Our thanks to the founders, executives and visionaries behind Fluent, including our co-investors at Samsara (Mike Dybbs) and Illumina VC (Wouter Meuleman): Sepehr Kiani, Kristina Fontanez, William (Bill) Hyun, Adam Abate, Brian McKernan, Gary Zweiger and many others. 

On a personal note, this marks my 3rd exit to Illumina as an investor/executive, and I'm humbled that our fund is able to play a role in building cutting-edge life sciences tools that are driving the future of biological innovation.

We are thrilled to announce the acquisition of our portfolio company, Fluent BioSciences Inc., by Illumina, marking the 10th exit for our fund.

Congratulations to the founders, executives and visionaries behind Fluent, including Sepehr Kiani and Brian McKernan.

🔈 CV Fireside Chat Series: Sourcing Innovation

We want to extend a heartfelt thank you to our speakers for the second installment of the "Sourcing Innovation" series, which focused on the journey of two CEOs who have successfully spun out their PhD projects.  

Shakked Halperin, PhD: CEO and Founder of Replace Therapeutics (Exited) and Rewrite Therapeutics (Exited), spun out of University of California, Berkeley

Marco Lobba, Ph.D.: CEO and Co-Founder of CatenaBio, spun out of University of California, Berkeley

In the Sourcing Innovation series, we aim to broaden the discussion around academic entrepreneurship by exploring the spin-out process from two crucial perspectives: the PIs who lay the groundwork and the PhD trainees-turned-CEOs who bring these innovations to market.

🇺🇸 Happy early 4th of July from our team at CV 🇺🇸 

If you are interested in learning more about the transformative potential of Generative AI in healthcare and life sciences, hear our founding GP Shahram Seyedin-Noor share his views as part of the Talk Gen AI panel at Swissnex below. 

#generativeai 

https://lnkd.in/gCmUzFgM

🔈 CV Fireside Chat Series: Sourcing Innovation

We want to extend a heartfelt thank you to our speakers for the first installment of the "Sourcing Innovation" series. This segment delves into the intricate process of spinning out technologies from academia, providing invaluable insights from our distinguished advisors:

Hani Goodarzi: Core Investigator Arc Institute, Associate Professor University of California, San Francisco

David Schaffer: Director Bakar Labs/QB3, Distinguished professor University of California, Berkeley

In the Sourcing Innovation series, we aim to broaden the discussion around academic entrepreneurship by exploring the spin-out process from two crucial perspectives: the PIs who lay the groundwork and the PhD trainees-turned-CEOs who bring these innovations to market.

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Apple Mobile Web Clips Icon

HSTS

Content Delivery Network

WordPress

Amazon

LetsEncrypt

Ha Nguyen

Founder + General Partner

Shahram Seyedin-Noor

Vice President

Themasap Khan

Venture Fellow

Ruxandra Tesloianu

Banking and Wealth Management

Sonia Maryam Setayesh

Founder and General Partner

Zoya Khan

Analyst

Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Kit is an online seller of consumer products.

Pillo Health is a healthcare solutions provider that empowers organizations to deliver better care into the home.

Singular Bio is a privately held company developing single molecule detection technology.

Early Stage Venture Investors with Investments in San Jose, California

Venture Capital Investors with Investments in Los Angeles, California

Late Stage Venture Investors with Investments in Oxfordshire

Late Stage Venture Investors with Investments in São Paulo, Sao Paulo

Civilization Ventures invests in visionary founders that are leading the future of health tech and biology-driven innovation. We aim to be the first check and lead investor in highly disruptive companies across digital health, synthetic biology, diagnostics, 3D (bio) printing, and AI/ software-enabled health tech. Our team comprises serial entrepreneurs and industry thought leaders who work tirelessly to help each of our portfolio companies succeed.

Civilization Ventures II, L.P.

San Francisco

California

United States

North America

BillionToOne: Molecular Diagnostics Company Raises $130 Million

Indonesia

Asia

Pakistan

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 5:09 AM	10d55e2e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	4647aa51
crunchbase profile	general	Nov 25, 2024 9:11 AM	191235b5
li profile	general	Jul 18, 2024 5:09 AM	79c03d77
translate crunchbase fundingrounds	general	Nov 25, 2024 2:00 PM	7a9109e8
peers	general	Jul 18, 2024 5:09 AM	a304da4a
news basic	general	Jul 18, 2024 5:09 AM	52bafb6c
bundesanzeiger	filings
financials download nd	financials
private financials	financials

CIVI

COM:CIVILIZATIONVENTURES

Civilization Ventures